Rheumatoid arthritis

A new study has provided more evidence gut bacteria plays a role in the development of rheumatoid arthritis. The research suggests an abnormal immune response to a common species of gut bacteria could influence the development of the disease.

Scientists studying the activity of a drug used to treat rheumatoid arthritis have discovered some surprising metabolic functions, some of which may be useful when it comes to countering diabetes and obesity.

A research team has discovered a novel mechanism in which a key protein drives the inflammatory damage associated with rheumatoid arthritis. The foundational finding could lead to entirely new pathways to treat this autoimmune disease affecting millions.

Positive Phase 3 trial results for a new antibody treatment targeting rheumatoid arthritis have recently been reported. The therapy is hoped to offer a new option to patients struggling with current treatments and should be available within the next year.

A new study from scientists in Japan and the US has identified a form of inter-neuron communication as a key mechanism in the way inflammation spreads between joints in conditions like rheumatoid arthritis.

A new discovery around inflammation and excessive cell death in the body illuminates the key role a certain enzyme plays in the process, and how targeting a "sugar tag" could lead to treatments for a wide range of conditions.

By tapping into the unique immune system of alpacas and special nanobodies they produce, scientists have developed a promising technique for tempering chronic inflammation associated with conditions such as arthritis.

Impressive research is suggesting bacterial imbalances in the gut microbiome may play a major role in the development of rheumatoid arthritis. The preclinical study found damage to the gut lining directly correlates with joint inflammation and severity.

Researchers at Washington University have tested an experimental new treatment for rheumatoid arthritis in mice. The team implanted stem cells that have been reprogrammed to secrete anti-inflammatory drugs only when they sense inflammation.

Although the drinking of hydrogen-gas-infused water can help treat rheumatoid arthritis, the effects are limited. Scientists have developed what could be a better alternative, though, in the form of tiny injectable gas-emitting "micromotors."

Although anti-inflammatory drugs can be used to tackle conditions like osteoarthritis, there are downsides to our current methods of delivery. New research at the Washington University School of Medicine in St. Louis could address these shortcomings.

The growing problem of antibiotic resistance isn’t slowing down, which could soon render our best drugs useless against infection. Now, an existing rheumatoid arthritis drug could be repurposed to cancel bacteria’s resistance to antibiotics.